Ubs Group Ag Acasti Pharma Inc. Transaction History

Ubs Group Ag

  • $400 Billion
  • Q2 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
BUY
$0.43 - $0.81 $1,609 - $3,032
3,744 New
3,744 $1,000
Q3 2022

Nov 10, 2022
BUY
$0.62 - $3.66 $15,058 - $88,894
24,288 New
24,288 $14,000
Q2 2022

Aug 10, 2022
SELL
$0.85 - $1.29 $1,009 - $1,532
-1,188 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$0.94 - $1.43 $1,116 - $1,698
1,188 New
1,188 $1,000
Q4 2021

Feb 14, 2022
SELL
$1.07 - $2.01 $4,815 - $9,044
-4,500 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$1.96 - $4.72 $8,820 - $21,240
4,500 New
4,500 $9,000

About Acasti Pharma Inc.

ACST Quotes by TradingView
  • Ticker ACST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,610,100
  • Market Cap $145M
  • Description
  • Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
More about ACST
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email